Now playing Sales of Novo Nordisk’s blockbuster weight loss drug Wegovy continue to soarPublishedNovember 6, 2024
Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drugByBruce GilPublishedNovember 4, 2024
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round upByBruce GilPublishedNovember 1, 2024
Knockoff weight loss drugs are having a moment. Eli Lilly isn't worriedByBruce GilPublishedOctober 30, 2024
Eli Lilly isn't selling as much Zepbound as expected — and the stock is sinkingByBruce GilUpdatedOctober 30, 2024
Ozempic and other weight loss drugs aren't lowering health care costs yetByBruce GilUpdatedOctober 25, 2024
